Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Reckitt ( (GB:RKT) ) has provided an announcement.
Reckitt is a leading consumer health and hygiene company whose products aim to protect, heal and nurture households worldwide through science-backed brands such as Dettol, Durex, Lysol and Nurofen. The company emphasises making everyday life easier, cleaner and healthier, while strengthening communities and supporting a more sustainable future through responsible innovation and social impact initiatives.
Reckitt will host a “Reckitt Focus On: Digital Science” investor seminar today, highlighting how it is combining proprietary data, predictive science and generative AI to accelerate innovation and drive productivity and category growth. Led by Chief R&D Officer Angela Naef and senior finance and digital executives, the live-streamed event is designed to give investors deeper insight into the company’s digital and R&D strategy without disclosing new financial or trading information.
The most recent analyst rating on (GB:RKT) stock is a Hold with a £5600.00 price target. To see the full list of analyst forecasts on Reckitt stock, see the GB:RKT Stock Forecast page.
Spark’s Take on RKT Stock
According to Spark, TipRanks’ AI Analyst, RKT is a Neutral.
The score is driven primarily by improved financial performance (notably profitability and lower leverage) and supportive valuation (moderate P/E and solid yield). These are tempered by weak technicals (below key moving averages with negative momentum) and earnings-call-flagged near-term pressures on cash flow, leverage, and 2026 margin/EPS visibility.
To see Spark’s full report on RKT stock, click here.
More about Reckitt
Reckitt is a global consumer goods company focused on health, hygiene and home care products, with a portfolio that includes brands such as Dettol, Durex, Finish, Gaviscon, Harpic, Lysol, Mucinex, Nurofen, Strepsils, Vanish and Veet. The group positions itself as a science-led innovator, developing products that support healthier lives while pursuing sustainability through reduced waste, resource conservation and expanded access to healthcare and education.
Average Trading Volume: 2,312,861
Technical Sentiment Signal: Sell
Current Market Cap: £29.25B
Learn more about RKT stock on TipRanks’ Stock Analysis page.

